Dr Gabriel Fernando Santiago, MD | |
601 N Caroline St, Jhoc 8161, Baltimore, MD 21287-0006 | |
(410) 955-9472 | |
(410) 614-1296 |
Full Name | Dr Gabriel Fernando Santiago |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 601 N Caroline St, Baltimore, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851608954 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | D81920 (Maryland) | Primary |
Entity Name | Johns Hopkins University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Walter and Eliza Hall Institute researchers in Melbourne, Australia, have discovered how a key viral gene helps viruses evade early detection by the immune system. Their finding is providing new insights into how viruses are able to establish chronic infections, leading scientists to reevaluate their approaches to viral vaccine development.
A warm-up program developed specially for children reduces soccer injuries by around 50 percent. Sports scientists from the University of Basel reported these findings in the academic journal Sports Medicine.
A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population.
The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.
About one-half percent of patients undergoing facelift surgery at one outpatient surgical center between 2001 and 2007 developed methicillin-resistant Staphylococcus aureus (MRSA) infections, according to a report in the March/April issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.
› Verified 3 days ago
Entity Name | Univ Of Maryland Otorhinolaryngology Head & Neck Surgery Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104832948 PECOS PAC ID: 8820026974 Enrollment ID: O20050729000661 |
News Archive
Walter and Eliza Hall Institute researchers in Melbourne, Australia, have discovered how a key viral gene helps viruses evade early detection by the immune system. Their finding is providing new insights into how viruses are able to establish chronic infections, leading scientists to reevaluate their approaches to viral vaccine development.
A warm-up program developed specially for children reduces soccer injuries by around 50 percent. Sports scientists from the University of Basel reported these findings in the academic journal Sports Medicine.
A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population.
The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.
About one-half percent of patients undergoing facelift surgery at one outpatient surgical center between 2001 and 2007 developed methicillin-resistant Staphylococcus aureus (MRSA) infections, according to a report in the March/April issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Gabriel Fernando Santiago, MD 601 N Caroline St, Jhoc 8161, Baltimore, MD 21287-0006 Ph: () - | Dr Gabriel Fernando Santiago, MD 601 N Caroline St, Jhoc 8161, Baltimore, MD 21287-0006 Ph: (410) 955-9472 |
News Archive
Walter and Eliza Hall Institute researchers in Melbourne, Australia, have discovered how a key viral gene helps viruses evade early detection by the immune system. Their finding is providing new insights into how viruses are able to establish chronic infections, leading scientists to reevaluate their approaches to viral vaccine development.
A warm-up program developed specially for children reduces soccer injuries by around 50 percent. Sports scientists from the University of Basel reported these findings in the academic journal Sports Medicine.
A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population.
The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.
About one-half percent of patients undergoing facelift surgery at one outpatient surgical center between 2001 and 2007 developed methicillin-resistant Staphylococcus aureus (MRSA) infections, according to a report in the March/April issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.
› Verified 3 days ago
Dr. David Jeffrey Eisenman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 16 S Eutaw St, Suite 500, Baltimore, MD 21201 Phone: 410-328-5828 Fax: 410-328-5827 | |
Dr. John R Saunders Jr., M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 6569 N Charles St, Suite 401, Baltimore, MD 21204 Phone: 443-849-8940 | |
Dr. John F. Biedlingmaier, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-6897 Fax: 410-328-2109 | |
Dr. David W Eisele, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Jhoc 6215, Baltimore, MD 21287 Phone: 410-955-1080 | |
Andrew Lane, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-1686 | |
Arain A. Waseem, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1576 Merritt Blvd, Suite # S-6, Baltimore, MD 21222 Phone: 410-282-7788 | |
Tony Yan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 6700 Ridge Rd, Suite 3, Baltimore, MD 21237 Phone: 410-391-3434 Fax: 410-574-7574 |